Reta (Retatrutide) for Getting Lean: What the Trials Show, What the Black Market Sells, and What Goes Wrong

Is "reta" safe to use for getting lean? No. Retatrutide is a real and very strong weight loss drug, but it is still being tested and is not approved anywhere in the world. Everything sold online, at gyms, or by "peptide" sellers is unapproved, and lab tests in 2026 found vials with the wrong amount of drug, or a different drug entirely. It has spread from bodybuilders to teens chasing a leaner face and abs. Here is what the trials actually show, what goes wrong with the black market version, and why it can make you look worse, not better.

What retatrutide is

Retatrutide is made by Eli Lilly. It copies three gut hormones at once (GLP-1, GIP, and glucagon), so people call it "triple G." Ozempic copies one, and Mounjaro copies two. The extra hormone, glucagon, makes the body burn more energy. Lilly says it is only legal to take inside its own clinical trials. Lilly plans to ask the FDA to approve it, and the BBC reported it would not be legal in the US until late 2027 at the earliest.

New research (2026)

The trial results are huge. Lilly announced in May 2026 that in its first big Phase 3 trial (TRIUMPH-1, 2,339 adults with obesity), people on the highest dose lost an average of 28.3% of their body weight over 80 weeks. The full study was published in the New England Journal of Medicine on September 29, 2026. These were people with an average BMI of 40, not lean gym goers.
Side effects were common, even with doctors watching. At the top dose, 42% had nausea, 32% diarrhea, 26% constipation, and 25% vomiting. About 1 in 8 at the higher doses had dysesthesia, which Lilly defines as a burning feeling on the skin and related symptoms, compared with about 1 in 100 on placebo. About 11% on the top dose quit because of side effects.
Online vials are a lottery (October 2026). A JAMA news report on October 9, 2026 described University of Queensland tests of three products labeled with the same amount of retatrutide. The real amount ranged from about half the label to about double. Sterility and bacterial toxins were not tested. In another case, Australia's drug regulator tested a product sold as retatrutide after a patient had a potentially deadly torn esophagus, and found no retatrutide at all, only a high dose of semaglutide (the drug in Ozempic).
Liver damage cluster (June 2026). Victoria's health department in Australia issued an alert on June 19, 2026 after six cases of acute liver injury since January in people using products labeled Retatrutide, "Reta," "R-10," or "R-20." Officials believe a contaminant may be to blame, and said all such products are at risk. Warning signs they list: tiredness, belly pain, itchy skin, dark urine, yellow eyes or skin, and easy bruising.
A wellness case report (October 2026). BMJ Case Reports described a woman in her mid 20s in Zurich who was hospitalized with five days of nonstop vomiting and diarrhea after a "life coach" with no medical training gave her four weekly injections of a product said to contain retatrutide. Drugs in the hospital did not stop it. She did not think of the shots as medicine, so she did not mention them at first.
UK reports. The BMJ reported in July 2026 that the UK drug regulator had 77 reports involving retatrutide, 59 of them serious, including the death of a man in his 30s, reported by a health worker in 2025, with drug related liver injury listed. The BMJ stressed this report shows a suspected link, not proof that the drug caused the death.

What people who tried it say

Wrong dose by accident. A 20 year old gym goer told the BBC in September 2026 that he accidentally took eight times the dose he meant to from a product he ordered online after friends at his gym recommended it. He described 72 hours of bad diarrhea and nausea and said it felt like a 20 kg weight on his stomach.
Heart symptoms that lingered. One user wrote in 2026 that the product they were sold was far stronger than they were told. After the second shot they nearly fainted boarding a plane, with a racing heart and panic. They stopped, went to the ER for palpitations, felt fine for almost a month, then the palpitations came back and sent them to the ER again.
Skin that hurts to touch. A 30 year old man said that after about 2 weeks most of his body became so sensitive that he winced when his partner touched him casually. With strong tiredness on top, he stopped going to the gym, the opposite of what he wanted.
First shot surprise. Another user said their resting heart rate went from 55 to 80 overnight after the first shot, along with a nightmare and a panic attack, which they said never happens to them.
Teens are using it. The New York Post reported in May 2026 on high school students buying "r3ta" through friends and encrypted apps, sometimes stacked with tanning peptides. An 18 year old said she used it because she could not lose "stubborn" weight from her face and stomach, and that she knew more people her age using peptides "than I could count."
Some people like it. Users in the BBC report said it silenced their "food noise," cut sugar cravings, and helped them lose weight fast. Those effects are real, which is exactly why the fake market is booming.

Why it can make you look worse

You lose muscle, not just fat. A 2026 review in the Annals of Internal Medicine found that in trials of related drugs like semaglutide and tirzepatide, a median of about 28% of the weight lost came from muscle related tissue. A 2026 meta-analysis found that diet programs that added weight training lost only about 17.5% of their weight as lean mass, compared with about 25% to 35% on these drugs. For someone who is already lean, losing muscle is the opposite of a glow up.
Your face can deflate. A 2025 Vanderbilt study of scans found people on GLP-1 drugs lost about 7% of the fat in the middle of the face for every 10 kg (22 lb) lost, mostly from the fat pads just under the skin. That is the "Ozempic face" look: hollow cheeks and an older look. It was a small study of only 20 patients, but facial plastic surgeons say they are seeing more of it.
Your heart rate goes up. In the 2023 Phase 2 trial, heart rate rose with dose and peaked around 24 weeks before easing. In a trial, a doctor checks that. On your own, you are guessing.

Lesser-known points

"Research use only" is a legal trick. The JAMA report said sellers use this label while still posting dosing advice, and the FDA had sent 21 warning letters tied to retatrutide since December 2024. One seller kept selling five weeks after its letter.
Lilly reported over 14,000 posts and sites. That is how many websites, ads, and social posts it says it flagged for illegally marketing the drug, per the BBC. Many "before and after" posts are ads.
Trial screening exists for a reason. A trial doctor told the BBC that participants get medical records checked, blood tests, and mental health and self harm screening before they get a single dose. Black market buyers skip all of that.
"Lab tested" papers prove little. The teen in the Post said her suppliers "had their official labs," yet the University of Queensland tests found labels off by about 2 times in both directions. A paper from the seller is not a test you ran.
It is not built for lean people. Every big trial was in people with overweight or obesity. There is no data on what this does to a lean 19 year old trying to see his jawline.

Positives and negatives

Positives: In real trials, under medical care, retatrutide caused large weight loss and improved blood pressure, cholesterol, and waist size for people with obesity. If it is approved, it could help many people who need it.

Negatives: It is not approved. Black market vials have the wrong dose or the wrong drug, and have been linked to liver injury, hospital stays, and at least one reported death under review. Even the real drug causes stomach problems in a large share of users, skin pain in some, and a faster heart rate. It burns muscle along with fat and can hollow out your face.

Bottom line

Reta is a serious obesity drug still in testing, being sold as a shortcut to abs by people who cannot tell you what is in the vial. For someone who is already close to lean, the trade is awful: you risk your liver, gut, and heart, you lose muscle, and you may end up with a gaunter, older looking face. Get lean the slow way with lifting, protein, and a small calorie cut, and keep your muscle and your face. If you want to know whether all that effort shows in your photos, The Face They See lets people of the opposite gender rank your photos for free.

Related guides

See all guides